✦ LIBER ✦

S4 Letrozole vs. Tamoxifen as adjuvant endocrine therapy for postmenopausal women in receptor-positive breast cancer. BIG 1-98: A prospective randomized double-blind phase III study

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interpreting breast international group

✍ Meredith M Regan; Karen N Price; Anita Giobbie-Hurder; Beat Thürlimann; Richard 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 368 KB

Design, conduct, and analyses of Breast

✍ Giobbie-Hurder, A.; Price, K. N; Gelber, R. D 📂 Article 📅 2009 🏛 SAGE Publications 🌐 English ⚖ 194 KB

0161 Letrozole vs. tamoxifen as adjuvant

✍ B. Thürlimann 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 53 KB

A randomized phase III trial of adjuvant

✍ J. Andersen; M. Andersson; K.W. Andersen; P. Dombemowsky; H.T. Mouridsen; C. Ros 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 300 KB

15 Five years of exemestane as initial t

✍ A. Hasenburg; C.J.H. van de Velde; C. Seynaeve; D.W. Rea; J. Vannetzel; R. Parid 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB